Correction to: Long-term results (> 12 years) of surgical treatment of perihilar cholangiocarcinoma: Application of a modified Nagoya approach at a western center - Scorecard - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Erratum: Outcomes After Over 12 Years of Surgical Management for Perihilar Cholangiocarcinoma Using a Modified Nagoya Technique in a Western Institution

  • By

  • İlgin Özden

  • Orhan Bilge

  • Nergiz Dağoğlu

  • Ayşen Yavru

  • Mine Güllüoğlu

  • Arzu Poyanlı

  • Yaman Tekant

  • Ahmet Kızir

  • September 21, 2026

Share

Clinical Scorecard: Erratum: Outcomes After Over 12 Years of Surgical Management for Perihilar Cholangiocarcinoma Using a Modified Nagoya Technique in a Western Institution

At a Glance

CategoryDetail
ConditionPerihilar Cholangiocarcinoma
Key MechanismsSurgical management using a modified Nagoya technique
Target PopulationPatients with perihilar cholangiocarcinoma
Care SettingSurgical oncology

Key Highlights

  • Correction of tables in the original article
  • Focus on long-term outcomes after surgical management
  • Use of modified Nagoya technique in a Western institution

Guideline-Based Recommendations

Diagnosis

    Management

      Monitoring & Follow-up

        Risks

          Patient & Prescribing Data

          Not specified in the erratum

          Not specified in the erratum

          Clinical Best Practices

            Related Resources & Content

            Original Source(s)

            Correction to: Long-term results (> 12 years) of surgical treatment of perihilar cholangiocarcinoma: Application of a modified Nagoya approach at a western center

            • by İlgin Özden, Orhan Bilge, Nergiz Dağoğlu, Ayşen Yavru, Mine Güllüoğlu, Arzu Poyanlı, Yaman Tekant, Ahmet Kızir

            • September 21, 2026

            Related Content

            The evolution of RTOG and NRG Oncology CNS tumors clinical trials

            Cost-Effectiveness of Smoking Cessation Interventions Integrated Into Lung Cancer Screening

            Multi-omics profiling reveals sphingolipid metabolism reprogramming of tumor-conditioned MDSCs in cervical cancer